Eli Lilly and Company (LLY)
FSX
Closed
Aug 21, 2026
Day's Range
1,057.8052 wk Range
596.60Overview - LLY - Eli Lilly and Company
Key Statistics
Valuation
Enterprise Value
860.69B
P/E (Trailing)
‪42.44‬
P/E (Forward)
‪51.13‬
PEG Ratio
‪1.61‬
Price / Sales (TTM)
‪12.13‬
Price / Book
‪33.06‬
EV / EBITDA
‪24.15‬
Profitability
Gross Margin
‪85.77%‬
Profit Margin
‪33.52%‬
Operating Margin
‪54.22%‬
Return on Assets
‪20.35%‬
Return on Equity
‪102.28%‬
Ownership
Shares Outstanding
891.50M
Float
888.95M
Held by Insiders
‪0.15%‬
Held by Institutions
‪85.41%‬
Price stats
Beta
‪0.50‬
50-Day Avg
‪1,025.87‬
200-Day Avg
‪908.84‬
Dividends
Payout Ratio
‪21.69%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LLY - Eli Lilly and Company
Peers - LLY - Eli Lilly and Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
- LLYFSXEli Lilly and Company967.12BMarket Cap+44.79%52-week change42.45P/E (Trailing)‪33.52%‬Profit Margin
- LLY0FSXEli Lilly CDR862.66BMarket Cap+42.05%52-week change37.71P/E (Trailing)‪33.52%‬Profit Margin
- JNJFSXJohnson & Johnson559.57BMarket Cap+34.23%52-week change31.59P/E (Trailing)‪21.48%‬Profit Margin
- JNJ0FSXJohnson & Johnson CDR515.60BMarket Cap+32.69%52-week change28.49P/E (Trailing)‪21.48%‬Profit Margin
- 4AB0FSXAbbVie Inc. CDR404.07BMarket Cap+27.27%52-week change75.63P/E (Trailing)‪9.80%‬Profit Margin
- 4ABFSXAbbVie Inc.400.95BMarket Cap+21.11%52-week change74.64P/E (Trailing)‪9.80%‬Profit Margin
- RHOFSXRoche Holding AG323.48BMarket Cap+28.47%52-week change24.76P/E (Trailing)‪19.60%‬Profit Margin
Profile Summary - LLY - Eli Lilly and Company
About
Eli Lilly and Company is a leading pharmaceutical company engaged in the discovery, development, manufacture, and sale of human pharmaceutical products. It focuses on innovative medicines addressing critical health needs in areas such as diabetes, oncology, immunology, neuroscience, obesity, cardiovascular diseases,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
